- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02753725
Effect of Fentanyl on Emergence Delirium (ED) on Children Undergoing Adeno-tonsilectomy at Kenyatta National Hospital (KNH)
July 15, 2016 updated by: Dr. Kirwa Elisha kiprono, University of Nairobi
Effect of Fentanyl Given Approximately Ten Minutes to the End of Surgery on Emergence Delirium in Children Undergoing Adeno-tonsilectomy at Kenyatta National Hospital: A Randomized Placebo Controlled Clinical Trial
This study will be a randomized double blind placebo controlled clinical trial among children undergoing adeno-tonsillectomy in KNH.
The intervention arm will comprise Fentanyl given at a dose of 1ug/while the placebo arm will be given normal saline at a volume equivalent to Fentanyl dose, treatment will be administered approximately ten minutes to the end of surgery determined by the time when the mouth gag will be removed.
The main outcome will be incidence of ED at the recovery room using Watcha scale and secondary outcomes will be delay in emergence time from anaesthesia and effectiveness of fentanyl in preventing ED.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 12 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
American Society of Anaesthesiologists classes (ASA) 1 and 2 children.
- ASA 1 - Normal healthy child scheduled for adeno-tonsilectomy.
- ASA 2 - Child with mild systemic disease without functional limitations.
- Children aged 1 to 12 years.
- Children undergoing elective adeno-tonsilectomy.
- Those children whose parents/guardians have given a written informed consent.
Exclusion Criteria:
- Children with genetic syndromes.
- Children with psychological/neurological behavioural disorders.
- Children with allergies to Fentanyl.
- Children with psychiatric disorders/ use of psychiatric medications.
- Use of sedative medications one hour prior to surgery.
- Children with developmental delay.
- Children coming in as day case.
- Children with airway problems not related to the surgery-sleep apnoea.
- Children less than 1 year and those above 13 years.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Fentanyl group
Fentanyl given at a dose of one micro gram per kilogram body weight
|
The intervention arm will comprise Fentanyl given at a dose of one microgram per kilogramme body weight administered approximately ten minutes to the end of surgery determined by the time when the mouth gag will be removed.
Other Names:
|
|
Placebo Comparator: normal saline group
placebo arm will be given normal saline at a volume equivalent to Fentanyl dose as per body weight.
|
the placebo arm will be given normal saline at a volume equivalent to Fentanyl dose per body weight,administered approximately ten minutes to the end of surgery determined by the time when the mouth gag will be removed
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The number of patients who develop emergence delirium in both arms
Time Frame: 30 minutes
|
the number of patients who develop emergence delirium within 30 minutes after general anaesthesia will be assessed using Watcha scale indicated in the study questionnaire,
|
30 minutes
|
|
the local incidence of emergence delirium.
Time Frame: 30 minutes
|
local incidence of emergence delirium will be determined by the percentage of those who develop emergence delirium in the placebo group within 30 minutes after general anesthesia as assessed by Watcha scale.
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the percentage of patients developing emergence delirium in fentanyl group with 30 minutes after general anaesthesia.
Time Frame: 30 minutes
|
the percentage of patients developing emergence delirium in both groups will be compared to determine if fentanyl prevents emergence delirium.
|
30 minutes
|
|
duration of emergence time from general anaesthesia in minutes
Time Frame: 30 minutes
|
the time taken to emerge from both arms will be compared to determine if fentanyl delays emergence time from general anaesthesia.
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (Actual)
July 1, 2016
Study Completion (Actual)
July 1, 2016
Study Registration Dates
First Submitted
April 11, 2016
First Submitted That Met QC Criteria
April 25, 2016
First Posted (Estimate)
April 28, 2016
Study Record Updates
Last Update Posted (Estimate)
July 18, 2016
Last Update Submitted That Met QC Criteria
July 15, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Pathologic Processes
- Nervous System Diseases
- Postoperative Complications
- Neurologic Manifestations
- Confusion
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Delirium
- Emergence Delirium
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Fentanyl
Other Study ID Numbers
- UNairobi 1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
conferences, report writing
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.